RevMAb Biosciences, Inc. — Form D
RevMAb Biosciences, Inc. of SOUTH SAN FRANCISCO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2018-02-15. The offering totals $6.0M, of which $2.3M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2018-02-15
- Form: D
- Accession: 0001667353-18-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $6.0M
- Amount sold: $2.3M
- Remaining: $3.7M
- Investors: 10
- Date of first sale: 2017-08-10
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-305697
Issuer
- Name: RevMAb Biosciences, Inc.
- CIK: 0001667353
- Entity type: Corporation
- Jurisdiction: CAYMAN ISLANDS
- Incorporated: 2012
- Address: 870 DUBUQUE AVE., SOUTH SAN FRANCISCO, CA, 94080
- Phone: 650-351-7327
Officers, directors & promoters (5)
| Name | Role | Location |
|---|
| Yaohuang Ke | Director | South San Francisco, CA |
| GEORGE LEE | Director | New York, NY |
| Yaohuang Ke | Executive Officer | South San Francisco, CA |
| Dean J Tsao | Director | Hillsborough, CA |
| George J Lee | Director | Sante Fe Springs, CA |
Other filings by this issuer (2)
More